STE vs UPB · P/E 25, rev $5.46B vs rev $2.4M
STERIS plc (STE) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
STE currently screens at market cap $19.43B and trailing P/E 25.1. UPB currently screens at market cap $407.3M.
Not investment advice. Open the STE and UPB stock pages for the full models.
Not investment advice.